Annual Total Long Term Liabilities
$10.05 M
-$3.30 M-24.73%
31 December 2023
Summary:
Pliant Therapeutics annual total long term liabilities is currently $10.05 million, with the most recent change of -$3.30 million (-24.73%) on 31 December 2023. During the last 3 years, it has risen by +$9.19 million (+1060.97%). PLRX annual total long term liabilities is now -90.97% below its all-time high of $111.33 million, reached on 31 December 2019.PLRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$59.89 M
-$237.00 K-0.39%
30 September 2024
Summary:
Pliant Therapeutics quarterly total long term liabilities is currently $59.89 million, with the most recent change of -$237.00 thousand (-0.39%) on 30 September 2024. Over the past year, it has increased by +$49.87 million (+497.65%). PLRX quarterly long term liabilities is now -46.20% below its all-time high of $111.33 million, reached on 31 December 2019.PLRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLRX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.7% | +497.6% |
| 3 y3 years | +1061.0% | +7822.1% |
| 5 y5 years | -83.9% | - |
PLRX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.7% | +1061.0% | -0.4% | +7822.1% |
| 5 y | 5 years | -91.0% | +1061.0% | -46.2% | +7822.1% |
| alltime | all time | -91.0% | +1061.0% | -46.2% | +7822.1% |
Pliant Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $59.89 M(-0.4%) |
| June 2024 | - | $60.13 M(+11.6%) |
| Mar 2024 | - | $53.88 M(+435.9%) |
| Dec 2023 | $10.05 M(-24.7%) | $10.05 M(+0.3%) |
| Sept 2023 | - | $10.02 M(-18.6%) |
| June 2023 | - | $12.31 M(-3.9%) |
| Mar 2023 | - | $12.81 M(-4.1%) |
| Dec 2022 | $13.36 M(+150.9%) | $13.36 M(-4.8%) |
| Sept 2022 | - | $14.03 M(-1.8%) |
| June 2022 | - | $14.28 M(+190.2%) |
| Mar 2022 | - | $4.92 M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $5.33 M(+514.9%) | $5.33 M(+604.4%) |
| Sept 2021 | - | $756.00 K(-6.0%) |
| June 2021 | - | $804.00 K(-3.7%) |
| Mar 2021 | - | $835.00 K(-3.6%) |
| Dec 2020 | $866.00 K(-99.2%) | $866.00 K(-9.0%) |
| Sept 2020 | - | $952.00 K(+0.1%) |
| June 2020 | - | $951.00 K(+2.1%) |
| Mar 2020 | - | $931.00 K(-99.2%) |
| Dec 2019 | $111.33 M(+78.6%) | $111.33 M(+1230.5%) |
| June 2019 | - | $8.37 M(+76.7%) |
| Dec 2018 | $62.33 M | - |
| Dec 2018 | - | $4.73 M |
FAQ
- What is Pliant Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Pliant Therapeutics?
- What is Pliant Therapeutics annual total long term liabilities year-on-year change?
- What is Pliant Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly long term liabilities year-on-year change?
What is Pliant Therapeutics annual total long term liabilities?
The current annual total long term liabilities of PLRX is $10.05 M
What is the all time high annual total long term liabilities for Pliant Therapeutics?
Pliant Therapeutics all-time high annual total long term liabilities is $111.33 M
What is Pliant Therapeutics annual total long term liabilities year-on-year change?
Over the past year, PLRX annual total long term liabilities has changed by -$3.30 M (-24.73%)
What is Pliant Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PLRX is $59.89 M
What is the all time high quarterly long term liabilities for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly total long term liabilities is $111.33 M
What is Pliant Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, PLRX quarterly total long term liabilities has changed by +$49.87 M (+497.65%)